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ew psychoactive substances
a  b  s  t  r  a  c  t
The  rapid  expansion  in the  number  and  use  of  new  psychoactive  substances  presents  a signiﬁcant  ana-
lytical  challenge  because  highly  sensitive  instrumentation  capable  of  detecting  a  broad  range  of  chemical
compounds  in  real-time  with  a low  rate  of false  positives  is required.  A  Selective  Reagent  Ionisation-Time
of  Flight-Mass  Spectrometry  (SRI-ToF-MS)  instrument  is  capable  of  meeting  all  of these  requirements.
With  its high  mass  resolution  (up  to  m/m  of  8000),  the  application  of  variations  in  reduced  electric
ﬁeld  strength  (E/N)  and  use  of  different  reagent  ions,  the  ambiguity  of  a  nominal  (monoisotopic)  m/z  is
reduced and  hence  the  identiﬁcation  of  chemicals  in  a complex  chemical  environment  with  a  high  level
of conﬁdence  is  enabled.  In this  study  we  report  the  use  of  a SRI-ToF-MS  instrument  to  investigate  the
reactions  of  H3O+, O2+, NO+ and  Kr+ with  10  readily  available  (at  the  time  of  purchase)  new  psychoac-rug detection
ranching ratios
tive  substances,  namely  4-ﬂuoroamphetamine,  methiopropamine,  ethcathinone,  4-methylethcathinone,
N-ethylbuphedrone,  ethylphenidate,  5-MeO-DALT,  dimethocaine,  5-(2-aminopropyl)benzofuran  and
nitracaine.  In  particular,  the  dependence  of  product  ion  branching  ratios  on the  reduced  electric  ﬁeld
strength for  all  reagent  ions  was  investigated  and  is  reported  here.  The  results  reported  represent  a  sig-
niﬁcant  amount  of  new  data  which  will  be of  use  for  the  development  of drug  detection  techniques
suitable  for  real  world  scenarios.
© 2013 Elsevier B.V. All rights reserved.. Introduction
The abuse of drugs is an important issue affecting today’s soci-
ty. Although many drug species are controlled by law, a market for
ew psychoactive substances (i.e. legal highs, research chemicals,
nd designer drugs) which are not controlled by drug legislation,
as recently emerged. These readily available drugs are increas-
ngly being used as substitutes for prohibited drugs, especially by
hose who are looking for a high, but who do not wish to commit a
riminal act [1].A review of the current literature shows that most new
sychoactive substances have received little scientiﬁc interest,
specially substances new to the market. For many of these
∗ Corresponding author. Tel.: +43 512 214 800 050; fax: +43 512 214 800 099.
E-mail address: philipp.sulzer@ionicon.com (P. Sulzer).
1 Current address: Helmholtz Zentrum München Research Unit Environmental
imulation (EUS), Ingolstädter Landstraße 1, 85764 Neuherberg, Germany.
387-3806/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.ijms.2013.12.009compounds the only up-to-date source of information (e.g. syn-
thesis, purity, side-effects, etc.) is to be found online in user
forums [2,3] and no data on properties like proton afﬁnity, ioni-
sation energy, etc. are available. As new psychoactive substances
regularly enter the market, it is important that broad-based ana-
lytical methods exist which have the ability to rapidly detect
them, without the need for major changes in operational proce-
dures. This rapid identiﬁcation is especially important if a user has
taken an unidentiﬁed drug and requires urgent medical treatment.
Gas chromatography–mass spectrometry (GC–MS) has tradition-
ally been used for the identiﬁcation of drugs [4], providing both
high selectivity and sensitivity. This comes at the expenses of fast
analysis, making a real-time and therefore on-the-spot analysis
impossible. Chemical test strips and ion mobility spectrometry
(IMS) are much faster methods of analysis, but these have a limited
selectivity [5].
Proton-Transfer-Reaction-Time of Flight-Mass-Spectrometry
(PTR-ToF-MS), which relies on the use of H3O+ as the reagent ion,
provides both a rapid detection capability and a high sensitivity
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pptv within seconds). In addition, the soft ionisation capabili-
ies of PTR-ToF-MS generally avoid signiﬁcant fragmentation of
he analytes which enables drug identiﬁcation with a high level
f conﬁdence (low rate of false positives). However, relying on a
ominal m/z  makes unambiguous identiﬁcation impossible. High
ass resolution instruments provide higher conﬁdence in assign-
ent, but still isomeric compounds cannot be ruled out. In addition
o changing operational parameters, e.g. the voltage applied to
he drift tube, the recently developed Selective Reagent Ionisa-
ion (SRI) technology, [6,7] to change the reagent ion and hence
lter the ion-molecule chemistry in the drift tube of a PTR-ToF-MS,
as signiﬁcantly increased the instrument’s selectivity, making it
 multidimensional technique [8]. Given that we  have used SRI in
his study, we will not refer to the instrument as PTR-ToF-MS, but
s a Selective Reagent Ionisation-Time of Flight-Mass Spectrometry
SRI-ToF-MS) instrument to reﬂect this multidimensional use.
Previous studies have illustrated the applicability of SRI-ToF-
S  to the detection of several illicit and controlled prescription
rugs [9] and numerous other threat substances, such as explosives
10–12], chemical warfare agent simulants and toxic industrial
ompounds [13–15]. In addition, it has been shown that for some
xplosives, selectivity can be enhanced by changing the voltage
pplied to the drift tube (e.g. with the use of H3O+ as the reagent
on, by increasing reduced electric ﬁeld strengths E/N – the ratio of
he electric ﬁeld, E, to the buffer gas number density, N, in the drift
ube – the protonated parent molecule signals of TNT and TNB are
ncreased) [12].
In this paper a detailed study of the principle prod-
ct ions observed following reactions of H3O+, NO+, O2+
nd Kr+ with a number of new psychoactive substances,
amely 4-ﬂuoroamphetamine, methiopropamine, ethcathinone, 4-
ethylethcathinone, N-ethylbuphedrone, ethylphenidate, 5-MeO-
ALT, dimethocaine, 5-(2-aminopropyl)benzofuran and nitracaine
for structural information see Fig. 1) is reported. In particular, the
ffects of E/N on the fragmentation pathways are also discussed
n detail. These datasets, which provide information on the exact
/z and E/N dependence for all abundant fragments and with all
our reagent ions, respectively, should help in the development of
 highly selective analytical technique for drug detection based on
RI-ToF-MS suitable for real world scenarios.
. Experimental
All new psychoactive substance samples were analysed using a
TR-TOF 8000 (IONICON Analytik GmbH, Austria) equipped with a
RI capability, thus allowing a change in the reagent ion used for
hemical ionisation from H3O+ to O2+, NO+ or Kr+. The reagent ions
nd the resulting product ions are separated and detected using a
oF mass analyser. PTR-ToF-MS and SRI have both been described
n detail in previous publications [6,7,16,17] and therefore they will
nly be brieﬂy discussed here.
For the production of H3O+ ions water vapour from a reservoir
f pure water enters a hollow cathode discharge source. Following
onisation and a series of ion-molecule reactions the resulting H3O+
ons are directed into the drift tube by an applied voltage gradient.
ithin the drift tube proton transfer reactions will take place only
ith those chemical species (M)  that have a proton afﬁnity (PA)
reater than that of water (PA(H2O) = 691 kJ mol−1) [18]. This could
ither be via non-dissociative proton transfer:
3O + M → MH+ + H2O (1)
nd/or via dissociative proton transfer:3O+ + M → [M − A]H+ + A + H2O (2)
here A represents an elimination of a molecule from the transient
rotonated parent molecule.ass Spectrometry 360 (2014) 28– 38 29
For the production of O2+, NO+ and Kr+, water vapour is replaced
by oxygen, an oxygen/nitrogen mix  and krypton, respectively. If
exothermic, the reactions with NO+, O2+ and Kr+ may  proceed via
charge transfer, which may  also be either non-dissociative:
X+ + M → M+ +X (3)
where X+ represents the reagent ion, and/or dissociative:
X+ + M → [M − B]+ +B + X (4)
resulting in the elimination of B from the parent ion. NO+ has
the lowest recombination energy (RE) of these three reagent ions
(9.3 eV) and therefore may  only charge transfer to neutral species
whose ionisation energies (IE) are less than 9.3 eV. However, reac-
tion of NO+ and a molecule may  also take place via a chemical
reaction, for example hydride abstraction:
NO+ + M → [M − H]+ + HNO (5)
Reaction with NO+ may  result in an adduct ion being formed:
NO+ + M + C → MNO+ + C (6)
where C represents a third body (the buffer gas) that is required to
remove some of the energy resulting from the association, without
which the adduct would dissociate rapidly.
The E/N value used can be rapidly adjusted by changing the
voltage applied across the drift tube; this enables the investi-
gation of fragmentation pathways potentially offering a more
selective method for compound identiﬁcation. In the reported
experiments the E/N value was varied between 85 and 225
Td (1 Td = 10−21 V m2) when H3O+, NO+ and O2+ were used as
reagent ions and between 45 and 115 Td for the investigations
using Kr+. The 10 new psychoactive substances studied, legal in
most European countries at the time of purchase, were obtained
from various online vendors. These new psychoactive substances
studied were 4-ﬂuoroamphetamine, methiopropamine, ethcathi-
none, 4-methylethcathinone, N-ethylbuphedrone, ethylphenidate,
5-MeO-DALT, dimethocaine, 5-(2-aminopropyl)benzofuran and
nitracaine. Most can be classiﬁed as cathinones or piperazines,
which include a large list of analogues of amphetamines, with
psychoactive and stimulant effects [19,20]. Most of the chemicals
were supplied in powder (or crystal) form. However, two  were
supplied in tablet form (4-ﬂuoroamphetamine and ethcathinone).
Therefore, before any measurements were taken these two com-
pounds were ﬁrst crushed into a ﬁne powder. This ensured that all
samples were of comparable surface area. All of the supplied chem-
icals were used with no puriﬁcation. In addition to the detection
of the advertised new psychoactive substance analysis with SRI-
ToF-MS enables the detection of most solvents, synthetic reagents
and intermediates, but not “extenders” (usually low cost inorganics
such as sodium bicarbonate), however due to low costs of produc-
tion and tough competition, with rankings in online forums, the use
of these “extenders” is less likely in new psychoactive substances
than in illegal drugs.
The following procedure was adopted for the dynamic
headspace sampling of all 10 chemicals with H3O+, NO+ and O2+
as the reagent ions. A few mg of the drug were added to a glass
vial, the vial was  then sealed with a septum. An inlet and an outlet
line (1/16th inch PEEK, internal diameter 1 mm,  VICI AG Interna-
tional) were inserted through the septum to allow for dynamic
headspace sampling. The inlet line was connected to a charcoal ﬁl-
ter so that puriﬁed laboratory air entered the vials. The outlet line
was  directly connected to the heated sampling line of the SRI-ToF-
MS instrument. Samples were heated to a temperature between
60 ◦C and 100 ◦C and the sampling line and drift tube were main-
tained at a temperature of 110 ◦C in order to minimise adsorption
of the analytes onto the surface and memory effects.
30 W.J. Acton et al. / International Journal of Mass Spectrometry 360 (2014) 28– 38
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mig. 1. Chemical structures of (a) 4-ﬂuoroamphetamine, (b) methiopropamine, 
thylbuphedrone, (g) ethylphenidate, (h) 5-MeO-DALT, (i) dimethocaine and (j) nit
Once the dynamic headspace concentration had equilibrated, an
nvestigation of the reaction processes as a function of E/N began.
or H3O+ the E/N value was increased from 85 to 225 Td in steps
f 5 Td. A similar range in the reduced electric ﬁeld was used for
O+ and O2+, but E/N was increased in ∼25 Td steps, as no signif-
cant changes in the product ion branching ratios were observed
or smaller variations in E/N. For Kr+ the method was similar to
he above with the only exception being that helium was used as
uffer gas, instead of charcoal ﬁltered air. This was required to pre-
ent loss of Kr+ via charge transfer to the main components of air
7]. The use of helium as the buffer gas necessitated restricting the
ange of the Kr+ E/N study to a maximum value of 115 Td, to prevent
lasma formation in the drift tube. Rapid switching between H3O+,
O+ and O2+ is possible (tens of seconds). However switching from
3O+ to Kr+ requires several (if not tens) of minutes, because of the
eed of a dry system [7].
Prior to the analysis of each chemical with a new reagent ion
n empty vial was connected to the instrument. The E/N was var-
ed over the same range used for the drugs, as described above,
n order to provide background mass spectra which could be sub-
racted from those obtained when using the drug sample. For all
easurements an integration time of 40 s was used.
. Results and discussion
Product ion branching ratios for each drug species are summ-
rised in Figs. 2–5 for reactions with H3O+, NO+, O2+ and Kr+,
espectively. Only product ions which have branching ratios of
reater than or equal to 3% within the E/N range studied have been
ncluded in the ﬁgures, because below this value there is greater
ncertainty as to whether they belong to the drug or to an impurity.
Table 1 summarises the product ions and their branching ratios
t a standard operating condition of 130 Td.
.1. 4-Fluoroamphetamine (4-FA)
.1.1. Reaction with H3O+
Fig. 2(a) shows the effect of changing E/N on product ion
ranching ratios when H3O+ is used as the reagent ion. It can be
een from the ﬁgure that the protonated parent molecule (m/z
54.10, [MH]+, C9H13FN+) dominates at E/N < 105 Td, whilst m/z
37.07 ([MH−NH3]+, C9H10F+) becomes the most abundant species
etween 105 and 135 Td. Above 135 Td the ion branching ratio of
/z 109.04 ([MH−C2NH7]+, C7H6F+) increases rapidly and becomes(2-aminopropyl)benzofuran, (d) ethcathinone, (e) 4-methylethcathinone, (f) N-
e.
the dominant fragment ion. These ionic species have also been
observed in a previous study using chemical ionisation–mass spec-
trometry [21]. However in that study the reagent gas used was
methane, resulting in higher reaction energies than associated with
the reagent ion H3O+ and hence increased fragmentation. Addi-
tional fragment ions were also detected in that earlier study, which
we  did not observe, the most notable at m/z 134 corresponding to
[MH−HF]+.
3.1.2. Reaction with NO+, O2+ and Kr+
When NO+ was used as the reagent ion, see Fig. 3(a), the domi-
nant product ion observed across the whole E/N range was at m/z
152.09, assigned to [M−H]+ (C9H11FN+). The parent ion, m/z  153.09,
was  observed with an ion branching ratio which decreased from 9%
to 4% as E/N was increased from 85 to 225 Td. An additional prod-
uct ion was observed at m/z 109.04 corresponding to [M−C2H6N]+
(C7H6F+), which became the dominant product ion above 225 Td.
A signiﬁcant mass spectral peak assigned to an impurity was seen
at m/z 124.03, which we  assume resulted from non-dissociative
charge transfer to 4-ﬂuorobenzaldehyde (C7H5OF+), one of the
reagents reported in the synthesis of the drug by the online com-
munity [22].
When O2+ was  used as the reagent ion, Fig. 4(a), the parent ion
peak was  not observed. Instead we observed a product ion at m/z
152.09 which we attribute to the [M−H]+ ion, a fragmentation path-
way  which has been observed previously following the reaction
of O2+ with chemical compounds [23], as well as product ions at
m/z 138.07 ([M−CH3]+, C8H9FN+) and m/z 109.04 ([M−C2H6N]+,
C7H6F+). As found with the NO+ study, we  also observed a mass
spectral peak at m/z 124.03 which we  attribute to a reaction with
an impurity.
Results similar to those found for O2+ and NO+ were observed
for the reactions with Kr+, Fig. 5(a), i.e. the same principle prod-
uct ions observed across the whole E/N range, namely ions at m/z
152.09 ([M−H]+, C9H11FN+), m/z 138.07 ([M−CH3]+, C8H9FN+) and
m/z 109.04 ([M−C2H6N]+, C7H6F+). Again a mass spectral peak at
m/z 124.03 (C7H5OF+) resulting from an impurity was observed.
3.2. Methiopropamine (MPA)3.2.1. Reaction with H3O+
The reaction of MPA  with H3O+, Fig. 2(b), results in three
main product ions, namely the protonated parent at m/z  156.08
([MH]+, C8H14SN+), m/z 125.04 ([MH−CH5N]+, C7H9S+) and m/z
W.J. Acton et al. / International Journal of Mass Spectrometry 360 (2014) 28– 38 31
Fig. 2. The variation of the percentage product ion branching ratios following the reactions of the various drug compounds with H3O+ as a function of E/N for (a) 4-
ﬂuoroamphetamine, (b) methiopropamine, (c) 5-(2-aminopropyl)benzofuran, (d) ethcathinone, (e) 4-methylethcathinone, (f) N-ethylbuphedrone, (g) ethylphenidate, (h)
5-MeO-DALT and (i) dimethocaine.
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Tig. 3. The variation of the percentage product ion branching ratios following the r
b)  methiopropamine, (c) 5-(2-aminopropyl)benzofuran, (d) ethcathinone, (e) 4-me
8.06 ([MH−C5H6S]+, C3H8N+). Signiﬁcant spectral peaks were also
bserved at m/z 151.06 and m/z  63.03; the latter is attributed to
aBH3CN, which has been reported as a reagent in the synthesis
f MPA  [24], and this is supported by a distinctive isotopic pattern.
he mass spectral peak at m/z  151.06 is unidentiﬁed.ns of the drug species with NO+ as a function of E/N for (a) 4-ﬂuoroamphetamine,
thcathinone, (f) N-ethylbuphedrone, (g) 5-MeO-DALT and (h) dimethocaine.
At E/N values below 135 Td the protonated parent molecule
was the dominant species, whilst both m/z 125.04 and m/z 58.06
increased with increasing E/N and m/z 58.06 (i.e. [MH−C5H6S]+,
C3H8N+) became the most abundant product ion at values greater
than 135 Td.
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wig. 4. The variation of the percentage product ion branching ratios following the 
b)  methiopropamine, (c) 5-(2-aminopropyl)benzofuran, (d) ethcathinone, (e) 4-me
.2.2. Reactions with NO+, O2+ and Kr+
For both, NO+ and O2+, Figs. 3(b) and 4(b), respectively, m/z 58.06
[M−C5H5S]+, C3H8N+) was the dominant product ion observed
cross the whole E/N range investigated. Above 155 Td the ion
ranching ratio of m/z  58.06 decreased slightly because a new
on channel opens resulting in a product ion at m/z 97.01, which
e identify as [M−C3H8N]+ (C5H5S+). Two additional ions werens of the drug species with O2+ as a function of E/N for (a) 4-ﬂuoroamphetamine,
thcathinone, (f) N-ethylbuphedrone, (g) 5-MeO-DALT and (h) dimethocaine.
observed for reactions with NO+ and O2+at m/z 111.99 and 169.02,
tentitatively assigned to C5H4SO+ and C7H7SNO2+, respectively.
The corresponding neutral species are known intermediates used in
the synthesis of MPA  [24]. Other, but unknown impurities resulted
in ion signals observed at m/z 149.98 and m/z 137.09.
Product ions at m/z  58.06 and m/z 97.01 were also observed
to result from reactions with Kr+ (Fig. 5(b)), with m/z 58.06 being
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ethiopropamine, (c) ethcathinone and (d) N-ethylbuphedrone.
gain the dominant one. However, an additional fragment ion was
bserved at m/z  73.05 which is tentatively assigned to C4H11N+, an
on that could be formed either via cleavage at the thiophene ring
i.e. [M−C4H2S]+), or from charge transfer to n-BuNH2, a compound
hich has been reported as a reagent in the synthesis of MPA  [24]
ut we consider this to be unlikely as it was not observed with
eactions of NO+ and O2+.
.3. 5-(2-Aminopropyl)benzofuran (5-APB)
.3.1. Reaction with H3O+
In the case of reactions with H3O+ (Fig. 2(c)), the dominant prod-
ct ion over the whole E/N range was at m/z 131.05 ([MH−C2H7N]+,
9H7O+). The protonated parent molecule ([MH]+, C11H14NO+)
as observed at m/z  176.11. Another peak observed in the mass
pectra was found at m/z 159.08. We  assign this to [MH−NH3]+
C11H11O+). The supplied sample of 5-APB showed major contrib-
tions from a series of impurities, mass spectral peaks observed
hich cannot be assigned to the drug, included m/z  119.03, m/z
01.02, and m/z  59.05 tentatively assigned to protonated benzofu-
an (C8H7O+), isopropenyl acetate (C5H8O2+), a solvent used in the
ynthesis of both 4-(2-aminopropyl)benzofuran (4-APB) and 6-(2-
minopropyl)benzofuran (6-APB), which are structural isomers of
-APB [25], and acetone (C3H7O+), respectively.
.3.2. Reactions with NO+, O2+ and Kr+
Two product ions attributed to 5-APB, which resulted from the
eaction with O2+ (Fig. 4(c)), i.e. m/z 175.12 ([M]+, C11H13NO+) and
/z 131.05 ([M−C2H6N]+, C9H7O+) were observed. In agreement
ith the study involving H3O+, the reaction of O2+ with the sup-
lied sample of 5-APB also indicates that it is impure, i.e. mass
pectral peaks observed at m/z  100.04 (ionised isopropenyl acetate,
5H7O2+) and at m/z 74.05 (an unknown compound). In the case
f NO+ (Fig. 3(c)), the same two products ions were observed, but
ith different branching ratios. A signiﬁcant impurity resulted in
n ion being observed at m/z  147.96. As a result of considerables of the drug species with Kr+ as a function of E/N for (a) 4-ﬂuoroamphetamine, (b)
fragmentation no product ions could be conﬁdently attributed to
5-APB following its reaction with Kr+.
3.4. Ethcathinone
3.4.1. Reactions with H3O+
Following reaction with H3O+ (Fig. 2(d)), the dominant product
ion observed at E/N values below 185 Td is the protonated par-
ent molecule at m/z 178.12 ([MH]+, C11H16NO+). Both m/z 160.11
([MH−H2O]+, C11H14N+) and m/z 132.08 ([MH−C2H6O]+, C9H10N+),
were also observed and their associated branching ratios are found
to increase with increasing E/N. Once E/N becomes greater than 185
Td, m/z 160.11 becomes the dominant product ion.
3.4.2. Reactions with NO+, O2+ and Kr+
The dominant product ion observed from the dissociative charge
transfer reaction with NO+ (Fig. 3(d)) was  m/z  72.08, assigned
to [M−C7H5O]+ (C4H10N+) which most probably is formed by -
cleavage at the ketone functional group. Other ions were observed
at m/z  105.04 ([M−C4H10N]+, C7H5O+), m/z  146.10, ([M−CH3O]+,
C10H12N+), m/z  175.10 ([M−H2]+, C11H13NO+) and m/z 176.12
([M−H]+, C11H14NO+). At E/N > 175 Td the fragments m/z  132.08
([M−C2H5O]+, C9H10N+) and m/z 130.07 ([M−C2H7O]+, C9H8N+)
were also observed. The use of O2+ as the reagent ion (Fig. 4(d))
led to the formation of many of the same product ions as
were identiﬁed with NO+, i.e. m/z 72.08 ([M−C7H5O]+, C4H10N+),
m/z 105.04 ([M−C4H10N]+, C7H5O+), m/z 132.08 ([M−C2H5O]+,
C9H10N+), m/z 146.10 ([M−CH3O]+, C10H12N+) and m/z 176.12
([M−H]+, C11H14NO+), with the ion at m/z 72.08 again being the
dominant fragment ion. Additional ions were seen at m/z 107.05
([M−C4H8N]+, C7H7O+), m/z 77.04 ([M−C5H10NO]+, C6H5+) and m/z
70.07 ([M−C7H7O]+, C4H8N+).
When Kr+ was  used as the reagent ion (Fig. 5(c)) only two sig-
niﬁcant product ions were observed in the mass spectra at m/z
72.08 which, as in case of NO+ and O2+, is the dominant fragment
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Table  1
List of the investigated drugs (in order of increasing mass) and the product ions and their associated percentage ion branching ratios (in brackets) for reactions with H3O+,
NO+, O2+ and Kr+, recorded at E/N of 130 Td (45 Td in case of Kr+). NR is used to represent no reaction and NOP means no observable product ions that can be identiﬁed to
the  drug as a result of substantial fragmentation.
Compound name H3O+ NO+ O2+ Kr+
4-Fluoroamphetamine
(C9H12FN; m/z 153.10)
m/z 154.10 – C9H13FN+ (19)
m/z 137.07 – C9H10F+ (44)
m/z 109.04 – C7H6F+ (37)
m/z 153.09 – C9H12FN+ (7)
m/z 152.09 – C9H11FN+ (64)
m/z 151.08 – C9H10FN+ (23)
m/z 109.04 – C7H6F+ (6)
m/z 152.09 – C9H11FN+ (24)
m/z 151.08 – C9H10FN+ (27)
m/z 138.07 – C8H9FN+ (17)
m/z 136.07 – C9H9F+ (11)
m/z 109.04 – C7H6F+ (21)
m/z 152.09 – C9H11FN+ (26)
m/z 138.07 – C8H9FN+ (34)
m/z 109.04 – C7H6F+ (40)
Methiopropamine (C8H13NS;
m/z 155.08)
m/z 156.08 – C8H14SN+ (36)
m/z 125.04 – C7H9S+ (19)
m/z 58.06 – C3H8N+ (45)
m/z  97.01 – C5H5S+ (1)
m/z 58.06 – C3H8N+ (99)
m/z 97.01 – C5H5S+ (2)
m/z 58.06 – C3H8N+ (98)
m/z 97.01 – C5H5S+ (6)
m/z 73.05 – C4H11N+ (7)
m/z 58.06 – C3H8N+ (87)
5-(2-Aminopropyl)benzofuran
(C11H13NO; m/z 175.10)
m/z 176.11 – C11H14NO+ (14)
m/z 159.08 – C11H11O+ (27)
m/z 131.05 – C9H7O+ (59)
m/z 175.12 – C11H13NO+ (32)
m/z  131.05 – C9H7O+ (68)
m/z 175.12 – C11H13NO+ (48)
m/z 131.05 – C9H7O+ (52)
NOP
Ethcathinone (C11H15NO; m/z
177.12)
m/z 178.12 – C11H16NO+ (90)
m/z 160.11 – C11H14N+ (10)
m/z 176.12 – C11H14NO+ (4)
m/z  175.10 – C11H13NO+ (3)
m/z 146.10 – C10H12N+ (3)
m/z  105.04 – C7H5O+ (10)
m/z  72.08 – C4H10N+ (80)
m/z 176.12 – C11H14NO+ (2)
m/z 146.10 – C10H12N+ (2)
m/z 107.05 – C7H7O+ (4)
m/z 105.04 – C7H5O+ (9)
m/z 77.04 – C6H5+ (2)
m/z 72.08 – C4H10N+ (73)
m/z 70.07 – C4H8N+ (8)
m/z 105.04 – C7H5O+ (4)
m/z 72.08 – C4H10N+ (96)
4-Methylethcathinone
(C12H17NO; m/z 191.13)
m/z 192.14 – C12H18NO+ (80)
m/z 190.13 – C12H16NO+ (18)
m/z 174.14 – C12H16N+ (2)
m/z 190.12 – C12H16NO+ (3)
m/z 119.05 – C8H7O+ (1)
m/z  72.08 – C4H10N+ (96)
m/z 119.05 – C8H7O+ (4)
m/z 91.05 – C7H7+ (5)
m/z 72.08 – C4H10N+ (91)
m/z 72.08 – C4H10N+ (100)
N-Ethylbuphedrone
(C12H17NO; m/z 191.13)
m/z 192.14 – C12H18NO+ (84)
m/z 190.13 – C12H16NO+ (13)
m/z 174.14 – C12H16N+ (3)
m/z 190.12 – C12H16NO+ (3)
m/z 105.03 – C7H5O+ (4)
m/z  86.10 – C5H12N+ (93)
m/z 105.03 – C7H5O+ (9)
m/z 86.10 – C5H12N+ (91)
m/z 162.10 – C10H12NO+ (40)
m/z 105.03 – C7H5O+ (60)
Ethylphenidate (C15H21NO2;
m/z 247.16)
m/z 248.16 – C15H22NO2+ (81)
m/z 165.09 – C10H13O2+ (1)
m/z 84.08 – C5H10N+ (18)
NR NOP NOP
5-MeO-DALT (C17H22N2O; m/z
270.13)
m/z 271.18 – C17H23N2O+ (91)
m/z 174.09 – C11H12NO+ (6)
m/z 160.08 – C10H10NO+ (3)
m/z  270.19 – C17H22N2O+ (14)
m/z  175.08 – C11H13NO+ (15)
m/z 159.06 – C10H9NO+ (26)
m/z 110.09 – C7H12N+ (45)
m/z 175.08 – C11H13NO+ (52)
m/z 110.09 – C7H12N+ (48)
NOP
Dimethocaine (C16H26N2O2;
m/z 278.20)
m/z 279.20 – C16H27N2O2+ (91)
m/z 142.16 – C9H20N+ (2)
m/z 120.04 – C7H6NO+ (4)
m/z 86.10 – C5H12N+ (3)
m/z  278.19 – C16H26N2O2+ (1)
m/z  165.07 – C9H11NO2+ (3)
m/z  86.10 – C5H12N+ (96)
m/z 149.03 – C8H7NO2+ (4)
m/z 120.05 – C7H6NO+ (5)
m/z 86.10 – C5H12N+ (91)
m/z 120.05 – C7H6NO+ (100)
i
o
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w
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n
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r
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3
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d
a
eNitracaine (C16H24N2O4; m/z
308.17)
Crystal: m/z 309.17 –
C16H25N2O4+ (100)
NR 
on [M−C7H5O]+ and m/z 105.04 ([M−C4H10N]+, C7H5O+) which is
bserved at comparatively low relative abundances.
No signiﬁcant contaminants were observed for reactions with
ny of the reagent ions, indicating that the supplied ethcathinone
as reasonably pure.
There is little data available in the literature on the mass spectral
nalysis of ethcathinone, but the GC–MS analysis of dimethylcathi-
one, a close structural isomer of ethcathinone, is reported [26].
his shows a fragmentation pattern comparable to the observed
esults obtained when the analyte was ionised via charge transfer
NO+, O2+ and Kr+) with the most abundant ion observed at m/z
2. However, GC–MS also observed a signiﬁcant peak at m/z 44
ssigned to the loss of ethane from the fragment at m/z 72 which
as not observed in the present study.
.5. 4-Methylethcathinone (4-MEC) and N-ethylbuphedrone
NEB)
The principle product ions observed when the structural iso-
ers 4-MEC and NEB react with H3O+, NO+, O2+ and Kr+ have been
iscussed previously [8] but only at an E/N of 130 Td for H3O+, NO+
nd O2+ and 95 Td for Kr+. Therefore we present here a much more
xtensive study with results covering a wide range in E/N.NR NOP
3.5.1. Reaction with H3O+
When H3O+ was  used as the reagent ion at low E/N values
(less than approximately 160 Td), the protonated molecular ion at
m/z 192.14 ([MH]+, C12H18NO+) was the dominant product ion for
both 4-MEC and NEB (Fig. 2(e) and (f)). Above 170 Td, m/z 174.14
([MH−H2O]+, C12H16N+) became the dominant product ion. An ion
with a constant branching ratio was observed at m/z  190.13 in
both 4-MEC and NEB, this is assigned to [MH−H2]+ (C12H16NO+).
The loss of H2 from the protonated parent molecule is a reaction
channel that has been observed in previous studies dealing with
illicit drugs with a similar structure [9]. At E/N > 135 Td, additional
peaks were observed at m/z 146.10 and m/z 91.06 in both isomers;
these masses are tentatively assigned to [MH−C2H8N]+ (C10H10O+)
and [MH−C5H11NO]+ (C7H7+) respectively. In the investigation of
NEB, an additional peak at m/z 118.07 was  observed at E/N > 150
Td, which is assigned to [MH−C4H12N]+ (C8H6O+). A mass spectral
peak observed at m/z 130.07 is assigned to result from a reaction
with an impurity.3.5.2. Reactions with NO+, O2+ and Kr+
The most signiﬁcant fragmentation pathway observed following
the reaction of NEB with NO+ and O2+ is  cleavage at the ketone
functional group leading to the formation of [M−C7H5O]+ at m/z
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6.10 (C5H12N+) (Figs. 3(f) and 4(f)). This product ion could not be
bserved in the Kr+ system as it falls within the same m/z value
s the very abundant 86Kr+ reagent ion. A second fragment ion
as observed with ion branching ratios below 10%, at m/z  105.03
[M−C5H12N]+, C7H5O+) when NEB was ionised by NO+ and O2+
ia dissociative charge transfer and higher ion branching ratios for
he reaction with Kr+ (Fig. 5(d)). Another product ion was observed
t m/z 162.10 ([M−C2H5]+, C10H12NO+) for the reaction with Kr+.
t should be noted that its branching ratio is artiﬁcially raised for
he Kr+ data because we cannot determine the product ion signal
trength at m/z  86.10. In the case of O2+ and NO+ the associated
ranching ratio for this product ion was less than 3% throughout
he complete E/N range and hence is not included in that data.
The dominant product ion formed from the reaction of 4-MEC
ith NO+, O2+ (Figs. 3(e) and 4(e)) and the only observed product
on for Kr+ was m/z 72.08 ([M−C8H7O]+, C4H10N+), formed via 
leavage at the ketone functional group, the same mechanism that
eads to the formation of the product ion [M−C7H5O]+ at m/z 86.10
n NEB. The product ion [M−C4H10N]+ at m/z 119.05, equivalent
o m/z  105.03 in NEB, was observed at ion branching ratios below
0% in the NO+ system. In both the NO+ and O2+ systems the tropy-
ium cation [M−C5H10NO]+ was observed at m/z 91.05 with its ion
ranching ratio increasing signiﬁcantly with increasing E/N.
.6. Ethylphenidate (EP)
.6.1. Reaction with H3O+
For H3O+ (Fig. 2(g)), the protonated parent molecule ([MH]+,
15H22NO2+, m/z 248.16) was the dominant product ion through-
ut the E/N range; its branching ratio began to decrease only at
/N > 200 Td, thus demonstrating a relatively high stability of the
rotonated species. Two principle fragment ions were detected,
ne at m/z  84.08 ([MH−C10H12O2]+, C5H10N+) and the other at m/z
65.09 ([MH−C5H9N]+, C10H13O2+); the latter was  only observed
or E/N < 135 Td. No signiﬁcant organic impurities were detected.
 similar fragmentation pattern was observed in previous studies,
here Gas Chromatography–Electron Ionisation-Mass Spectrom-
try (GC–EI-MS) was used, although it is not possible to make a
omparison of the branching ratios, due to the different nature of
he ionisation methods [27].
.6.2. Reaction with NO+, O2+ and Kr+
No reaction with NO+ was observed, not even adduct forma-
ion. For O2+ and Kr+ dissociative charge transfer dominated and
ery high levels of fragmentation were observed, thus preventing
dentiﬁcation of any characteristic peaks.
.7. 5-MeO-DALT
.7.1. Reaction with H3O+
Reaction with H3O+ (Fig. 2(h)) showed that the protonated
arent molecule ([MH]+, C17H23N2O+, m/z 271.18) dominated for
/N < 185 Td; at higher E/N values m/z 174.09 ([MH−C6H11N]+,
11H12NO+, -cleavage at the amino group) became the most
bundant species. A third fragment ion, which was  present at
ow branching ratios (<3%) at E/N < 155 Td but which increased to
0% by E/N 225 Td, was detected at m/z 160.08 ([MH−C7H13N]+,
10H10NO+). This fragment ion is most likely formed via -cleavage
t the amino group.
.7.2. Reaction with NO+, O2+ and Kr+
When NO+ was used as the reagent ion (Fig. 3(g)), at E/N val-
es below 150 Td the dominant peak was observed at m/z 110.09
hich is considered to be [M−C10H10NO]+ (C7H12N+), correspond-
ng to a tertiary amine fragment. The branching ratio of the parent
on, m/z 270.19 ([M]+, C17H22N2O+), decreases from 25% to 6% asass Spectrometry 360 (2014) 28– 38
E/N is increased from 85 Td to 225 Td. Two  additional ions were
observed i.e. m/z 175.08 and m/z 159.06, tentatively identiﬁed as
[M−C6H9N]+ (C11H13NO+) and [M−C7H13N]+ (C10H9NO+), respec-
tively. When O2+ was  used as the reagent ion (Fig. 4(g)), the parent
ion peak was not observed, whilst m/z 175.08 and m/z 110.09 were,
again, detected. Finally, when Kr+ was used as the reagent ion, dis-
sociative charge transfer dominates. However, the very high levels
of fragmentation observed prevent the identiﬁcation of any char-
acteristic peaks.
3.8. Dimethocaine
3.8.1. Reaction with H3O+
Reaction of dimethocaine with H3O+ led to the production of
4 signiﬁcant ions (Fig. 2(i)). Nondissociative proton transfer at
m/z  279.20, ([MH]+, C16H27N2O2+), dominates across the whole
E/N range investigated. At E/N greater than 185 Td fragment ions
were observed at m/z 120.04 ([MH−C9H21NO]+, C7H6NO+) and
142.16 ([MH−C7H7NO2]+, C9H20N+) assigned to  and  cleavage
at the ester functional group respectively. The product ion observed
at m/z 86.10 remains at a constant low branching ratio for the
whole E/N range investigated and is assigned to [MH−C11H15NO2]+
(C5H12N+).
Unidentiﬁed peaks observed in the mass spectra at m/z  307.24,
m/z 265.19, m/z 251.18 and m/z 124.04, are attributed to reactions
with unknown impurities in the sample. It has been suggested
[3,28] that the synthesis of dimethocaine could proceed via the
condensation of diethylamino-t-butanol and 4-aminobenzoic acid
ethyl ester. The latter has a protonated parent molecule at m/z
166.09; this m/z was observed and therefore attributed to a reactant
(or possibly an intermediate product) in the synthesis of dimetho-
caine.
Two  additional ions at m/z 160.17 and m/z 138.06 are tentatively
assigned to be C9H22NO+ and C7H8NO2+ respectively. These two
ions may  both be formed from proton transfer reactions with a
neutral species formed by hydrolysis of dimethocaine producing
3-(diethylamino)-2,2-dimethylpropanol and 4-amino benzoic acid.
3.8.2. Reactions with NO+, O2+ and Kr+
Following reaction with NO+ (Fig. 3(h)) the fragment ion
[M−C11H24NO2]+ at m/z 86.10 becomes the dominant product
ion across the E/N range investigated although the parent ion at
m/z 278.19 ([M]+, C16H26N2O2+) is still detected at ion branching
ratios below 10%. At E/N greater than 185 Td a mass spec-
tral peak is seen at m/z 165.07 which is tentatively assigned
to [M−C7H15N]+ (C9H11NO2+). The fragment ion at m/z 86.10
dominates throughout the E/N range investigated when O2+ is
used as the reagent ion (Fig. 4(h)), with additional ions at m/z
149.03 and m/z 120.05 assigned to [M−C8H19N]+ (C8H7NO2+) and
[M−C9H20NO]+ (C7H6NO+), respectively. Only one signiﬁcant prod-
uct ion is observed when Kr+ is used as the reagent ion at m/z  120.05,
attributed to [M−C9H20NO]+ (C7H6NO+). No previous determina-
tion of the fragmentation pathways via chemical ionisation have
come to our attention but a study of a related compound (procaine
using positive-ion ESI) revealed similar fragmentation pathways
[29] with  and  cleavage at the ester functional group also
observed.
Following reactions with NO+, O2+ and Kr+, the most signiﬁcant
contaminant observed was at m/z 137.12 (C7H7NO2+) which agrees
with the amino benzoic acid impurity found at m/z  138.06 from
the H3O+ reaction. Additional ions resulting from reactions with
impurities were observed at m/z 223.27 and 230.33 for NO+ and at
m/z 53.01 in the O2+ system.
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.9. Nitracaine
Two batches with a different appearance, i.e. one in powder
nd one in ﬁne crystal form, were analysed. The powder form of
itracaine did not show any mass spectral peak which could be
ttributed with any degree of certainty to nitracaine using any of
he reagent ions, suggesting that it contained no active ingredient.
.9.1. Reaction of powder form with H3O+
In the case of H3O+, the principle mass spectral peak over the
hole the E/N range was observed at m/z  160.17 (C9H22NO+).
his is tentatively attributed to protonated 3-(diethylamino)-2,2-
imethylpropanol, a reagent which may  be used in nitracaine
ynthesis [3,28]. Support for this assignment comes from the fact
hat this compound is a known irritant [30], and several online
ser forums mentioned that nasal irritation occurs following the
se of nitracaine [2,3]. Additional ions were observed at m/z 86.10
C5H12N+), m/z 142.10 (C9H20N+, loss of water from the amino alco-
ol) and m/z  158.15 (C9H20NO+, loss of H2 from the amino alcohol)
nd m/z 63.02, tentatively assigned to HNO3+.
.9.2. Reaction of powder form with NO+, O2+ and Kr+
When O2+ was used as a reagent ion, m/z  86.10 was
gain observed, this was the dominant ion. An additional ion
as observed at m/z 128.14, tentatively attributed to C8H18N+,
ormed by the dissociative charge transfer reaction of O2+ with
-(diethylamino)-2,2-dimethylpropanol, whilst two unidentiﬁed
eaks, were detected at m/z 93.99 and 99.96. In the case of NO+,
/z 86.10 was again the dominant ion. Additional peaks with lower
ranching ratios were observed at m/z 142.10 (tentatively assigned
o C9H20N+), m/z 158.15 (C9H20NO+) and again an unknown peak
t m/z 93.99. Reaction with Kr+ shows no signiﬁcant peaks in the
ass spectra.
.9.3. Reaction of crystal form with H3O+
Many of the ions observed in the nitracaine powder form are
lso observed following reaction of the crystal form with H3O+
ut in this case a mass spectral peak corresponding to the proton-
ted molecule was observed at m/z 309.17 ([MH]+, C16H25N2O4+).
his indicates that unlike the powder, the crystalline form con-
ains nitracaine. Other ions were detected at m/z  160.17 (C9H22NO+,
gain the dominant mass spectral peak over the whole E/N range),
/z 86.10 (C5H12N+) and two unknown mass spectral peaks at m/z
07.05 and 101.02. Furthermore, a peak at m/z 63.02, corresponding
o HNO3+, was observed.
.9.4. Reaction of crystal form with NO+, O2+ and Kr+
The only ions detected formed from the reaction of the reagent
on with impurities in the sample, as mentioned above for the pow-
er form, but identical m/z values were not necessarily observed.
wo ions, corresponding to C5H12N+ and C7H4NO3+, at m/z 86.10
nd m/z  149.95, were detected for reactions with O2+ and NO+,
ith m/z  86.10 always being the most abundant. When O2+ was
sed as the reagent ion, an impurity at m/z 63.02, assigned to
NO3+ was detected; while after switching to NO+, an ion at
/z 142.10 (C9H20N+) became signiﬁcant. When Kr+ was  used as
he reagent ion a large number of low intensity mass spectral
eaks were observed preventing identiﬁcation of any characteristic
eaks.
The fact that the molecular parent ion was observed in the crys-
al but not in the powder form indicates that the supplied nitracaine
n powder form contained nitracaine at insufﬁcient levels to be
etected (probably because of improper synthesis), thus explain-
ng contradictory reports on the effect of nitracaine seen on online
ser forums [2,3].
[
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4. Conclusions
Although some impurities were found in the drugs, all of the
supplied compounds with the exception of nitracaine powder were
found to contain the advertised active ingredient. This is surprising
considering drugs counselling reports [31] on designer drugs (e.g.
ecstasy = MDMA)  purchased from the black market, which can con-
tain virtually everything, from various mixtures of legal and illegal
ingredients to common caffeine.
The fast pace of legislation designed to control new psychoactive
substances leads to extremely short “invention to market” times
and thus to increasing risks for the consumers; e.g. in the unfortu-
nate case of the very recent UK ban on 5-APB, which was replaced
by the presumably highly toxic 5-EAPB that has already caused
fatalities among its ﬁrst users [32]. However, the rapid spread of
new psychoactive substances [33] means that the ability to rapidly
detect and identify these species is gaining increasing importance
for both policing and medical applications.
The reported product ion branching ratios formed from the anal-
ysis of a number of common new psychoactive substances (some,
while legal at the time of purchase, are now controlled in some
countries) by SRI-ToF-MS is designed to provide a reference for
the development of techniques, capable of identifying these drug
species in more complex ‘real world’ environments. These results
add to the already large list of threat compounds detectable by SRI-
ToF-MS. The potential role of this technology for the detection of
threat agents has been established including research focusing on
the detection of rape drugs in beverages [34]. This paves the way
for the application of this technology to real-world situations, such
as the detection of compounds adhered to surfaces (e.g. skin or
fabrics) and the rapid identiﬁcation of the constituents of blended
drugs.
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